Lukas Biomedical (ROCO:6814) Days Sales Outstanding : 19.22 (As of Jun. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Lukas Biomedical Days Sales Outstanding?

Lukas Biomedical's average Accounts Receivable for the six months ended in Jun. 2023 was NT$12.0 Mil. Lukas Biomedical's Revenue for the six months ended in Jun. 2023 was NT$114.3 Mil. Hence, Lukas Biomedical's Days Sales Outstanding for the six months ended in Jun. 2023 was 19.22.

The historical rank and industry rank for Lukas Biomedical's Days Sales Outstanding or its related term are showing as below:

ROCO:6814' s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.24 Med: 32.04 Max: 67.91
Current: 17.24

During the past 5 years, Lukas Biomedical's highest Days Sales Outstanding was 67.91. The lowest was 17.24. And the median was 32.04.

ROCO:6814's Days Sales Outstanding is ranked better than
91.67% of 888 companies
in the Biotechnology industry
Industry Median: 72.34 vs ROCO:6814: 17.24

Lukas Biomedical's Days Sales Outstanding increased from Jun. 2022 (12.19) to Jun. 2023 (19.22).

Lukas Biomedical Days Sales Outstanding Historical Data

The historical data trend for Lukas Biomedical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lukas Biomedical Days Sales Outstanding Chart

Lukas Biomedical Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

67.91

53.36

32.04

20.25

17.57

Lukas Biomedical Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Days Sales Outstanding	Get a 7-Day Free Trial					31.49	23.81	12.19	16.86	19.22

Competitive Comparison of Lukas Biomedical's Days Sales Outstanding

For the Biotechnology subindustry, Lukas Biomedical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lukas Biomedical's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lukas Biomedical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Lukas Biomedical's Days Sales Outstanding falls into.

Lukas Biomedical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Lukas Biomedical's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (5.706	+	12.087)	/	2 )	/	184.787	*	365
=	8.8965					/	184.787	*	365
=	17.57

Lukas Biomedical's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding (Q: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (12.087	+	11.985)	/	2 )	/	114.273	*	365 / 2
=	12.036					/	114.273	*	365 / 2
=	19.22

Lukas Biomedical (ROCO:6814) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Lukas Biomedical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Lukas Biomedical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Lukas Biomedical (ROCO:6814) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lukas Biomedical Inc (ROCO:6814) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xinyi Road, Da'an District, 3rd Floor, No. 2, Lane 265, Section 4, Taipei, TWN

Website

https://www.lukas-bio.com.tw

Lukas Biomedical Inc is engaged in the research and development of immunotherapy for cancer treatment technologies. It researches on the Memory T cell (LuLym-T) to improve the clinical outcome of cancer treatment.

Lukas Biomedical (ROCO:6814) Headlines

No Headlines